| Market Cap | 3.89M | P/E | - | EPS this Y | 67.80% | Ern Qtrly Grth | - |
| Income | -23.98M | Forward P/E | -2.51 | EPS next Y | 78.00% | 50D Avg Chg | -13.00% |
| Sales | 23.45M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -83.00% |
| Dividend | N/A | Price/Book | 0.08 | EPS next 5Y | - | 52W High Chg | -97.00% |
| Recommedations | 2.00 | Quick Ratio | 0.44 | Shares Outstanding | 3.05M | 52W Low Chg | 3.00% |
| Insider Own | 21.19% | ROA | -17.64% | Shares Float | 2.50M | Beta | 2.09 |
| Inst Own | 8.06% | ROE | -118.82% | Shares Shorted/Prior | 226.41K/244.19K | Price | 1.38 |
| Gross Margin | 63.84% | Profit Margin | -85.21% | Avg. Volume | 69,722 | Target Price | 2.00 |
| Oper. Margin | -19.83% | Earnings Date | May 13 | Volume | 8,962 | Change | -3.50% |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
| Maxim Group | Buy | Oct 5, 23 |